|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 397.6 USD | -0.03% |
|
+0.83% | -2.29% |
By Kathryn Hardison
Vertex Pharmaceuticals Inc.'s board of directors has approved a new share repurchase program for up to $3 billion of common stock.
The program doesn't have an expiration date and can be discontinued at any time, the company said Tuesday.
The board approved the new program on Feb. 1.
Write to Kathryn Hardison at kathryn.hardison@wsj.com
(END) Dow Jones Newswires
02-07-23 1622ET
| 1st Jan change | Capi. | |
|---|---|---|
| -2.27% | 103B | |
| +0.48% | 95.71B | |
| +1.69% | 22.02B | |
| -16.96% | 20.9B | |
| -9.30% | 17.85B | |
| -41.01% | 16.21B | |
| -14.47% | 15.52B | |
| +3.26% | 13.86B | |
| +35.18% | 12.04B | |
| -25.05% | 8.08B |
VERTEX PHARMACEUTICALS INCORPORATED 
